GlassScriptPhysician profile
Scott L Hansen
NPI 1548224694
$185,979.94
in general payments reported to CMS, 2019-2025
15 companies · $2,627 in 2025
The $2,627 reported for 2025 was more than what 85% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51K · 2020: $9,297 · 2021: $4,378 · 2022: $62K · 2023: $32K · 2024: $25K · 2025: $2,627.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Travel and Lodging: $21K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,140 · Food and Beverage: $5,896.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,125.00 |
| Travel and Lodging | $21,315.58 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,140.00 |
| Food and Beverage | $5,895.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $92,165.67 | 2020-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $87,466.63 | 2019-2023 | Versajet |
| Musculoskeletal Transplant Foundation INC. | $2,031.49 | 2023-2025 | |
| Kerecis Limited | $1,398.26 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Biotissue Holdings INC. | $676.00 | 2023-2025 | |
| Medical Microinstruments, INC. | $594.86 | 2024 | Symani Surgical Systems |
| Axogen | $552.51 | 2019-2025 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Cap |
| Endo Pharmaceuticals INC. | $199.58 | 2019 | |
| Alafair Biosciences, INC. | $196.53 | 2025 | Versawrap |
| Skeletal Dynamics INC | $151.47 | 2024 | Geminus, Ijs, Implate |
| Zimmer Biomet Holdings, INC. | $145.48 | 2019 | |
| Tei Biosciences INC | $131.67 | 2019 | |
| Stryker Corporation | $125.35 | 2025 | Variax |
| Medline Industries LP | $77.60 | 2019-2020 | |
| Ethicon US, LLC | $66.84 | 2025 | Dermabond Prineo, Stratafix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.